Post Subject #592   0 GTHP tests for cervical cancer. TREND1 09/24/18 12:32:34 PM #591   0 Sorry but the price Disagrees with you. TREND1 09/24/18 10:41:37 AM #590   0 No doubt. GTHP Cancer text will definitely replace otced 09/24/18 10:34:33 AM #589   0 How much must the doctor invest ? TREND1 09/24/18 05:18:41 AM #588   0 I have used their test, it is easy TREND1 09/24/18 05:01:17 AM #587   0 International Stock with 4B Customers guaranteed. otced 09/24/18 12:41:08 AM #586   0 Insider % Owned = 87.00% TREND1 09/22/18 05:55:24 PM #585   0 PE=0 TREND1 09/22/18 05:54:22 PM #584   0 EPS = -0.99 TREND1 09/22/18 05:54:11 PM #583   0 EXAS 1 YEAR TREND1 09/22/18 05:52:40 PM #582   0 GTHP:International Stock with 4B Customers guaranteed. otced 09/22/18 05:29:38 PM #581   0 EXAS 5 20 50 200 EMA TREND1 08/25/18 11:53:45 AM #580   0 Float = 119.32M TREND1 08/25/18 11:42:24 AM #579   0 Profit/Loss = $ -114.4M TREND1 08/25/18 11:41:32 AM #578   0 Market Cap $ 8.66B TREND1 08/25/18 11:40:04 AM #577   0 EXAS MONTHLY TREND1 08/25/18 11:37:54 AM #576   0 EXAS, PFE ink 3-year co-marketing deal for Cologuard: DewDiligence 08/22/18 09:33:13 AM #575   0 yeah looks very promising perhaps as much as ranjo 07/23/18 06:58:36 PM #574   0 EXAS liquid biopsy for HCC shows promise: DewDiligence 06/05/18 05:15:31 PM #573   0 Hello Dew, do you know what is the lgonber 04/11/18 06:20:48 AM #572   0 Nice buy, I never got anymore. just-for-fun 02/26/18 11:51:08 AM #571   0 Same here. Conference call sounded positive too. I D_A 02/23/18 09:48:44 AM #570   0 I thought the quarter and year were good, just-for-fun 02/22/18 07:14:28 PM #569   0 EXAS -9% on Taiwanese liquid-biopsy test profiled by DewDiligence 01/17/18 10:37:44 AM #568   0 *****Very good article IMHO. TREND1 11/21/17 11:37:14 AM #567   0 ***** Cologuard has no competition at this time. TREND1 11/16/17 02:11:57 PM #566   0 Nov 16, 2017 video on cologuard TREND1 11/16/17 01:37:34 PM #565   0 My GI is mailing me a Cologuard® after TREND1 11/16/17 12:52:03 PM #564   0 EXAS 30 MIN DAY WEEK TREND1 11/16/17 12:48:43 PM #563   0 Cologuard® revenue increased 158 percent to $73 million TREND1 11/16/17 12:15:09 PM #562   0 NET LOSS FOR Q3 = -27 M TREND1 11/14/17 01:25:53 PM #561   0 The Exact Sciences team delivered another strong quarter TREND1 11/14/17 01:03:29 PM #560   0 EXAS 30 MIN TREND DOWN TREND1 11/14/17 12:42:59 PM #559   0 EXAS DAY TREND1 11/14/17 12:30:46 PM #558   0 Earnings Per Share (EPS)= -1.63 TREND1 11/14/17 12:24:06 PM #557   0 Float = 108.69M TREND1 11/14/17 12:23:18 PM #556   0 Profit/Loss = $ -167.21M TREND1 11/14/17 12:22:30 PM #555   0 EXAS WEEKLY 9 YEARS TREND1 11/14/17 12:20:20 PM #554   0 Hey DewDiligence! maxxam 11/12/17 06:56:34 AM #553   0 bfost, I think we are getting closer to ranjo 11/05/17 07:02:32 PM #552   0 My favorite biotechs now are RVNC and ENTA. DewDiligence 11/04/17 04:48:14 PM #551   0 Hey Dew (Biko), can you please share about maxxam 11/04/17 09:11:07 AM #550   0 yup UPOD - beat and raise. bfost 10/31/17 12:55:07 PM #549   0 EXAS always lowballs the quarterly guidance. DewDiligence 10/31/17 11:58:19 AM #548   0 I'm a bit surprised by the strength of bfost 10/31/17 11:53:59 AM #547   0 EXAS +8%/AH/to-ATH on 3Q17 results: DewDiligence 10/30/17 04:32:33 PM #546   0 Management has refused to say when they expect DewDiligence 10/22/17 06:41:26 PM #545   0 What percentage of market does EXAS need to r clarke 10/22/17 06:26:31 PM #544   0 I have it figured in the same neighborhood, IronPantz 10/01/17 06:19:04 PM #543   0 I have this at 3.3 million test annually ranjo 09/27/17 04:43:23 PM Post Subject

© 2018 InvestorsHub.com, Inc.